Fox News host Eric Bolling defended Martin Shkreli’s business moves on Tuesday, saying that raising the price of the drug Daraprim to $750 per pill was sound business, Media Matters reported.
“Be careful before you call for this guy’s head,” Bolling said. “It’s the free market that provides the profit motive that entices drug companies to risk their own money to discover cures for diseases. Now think about this for one second: God help us if we left that to the government.”
Co-host Juan Williams quickly challenged Bolling’s argument.
“He has now simply taken advantage of the fact that he could get it, and taking advantage of people who need the drug,” Williams said, as Bolling said, “No one else wanted it.”
“No one else wanted it,” Bolling countered. “There could be a generic equivalent that comes out. If it stays at, whatever it is, $750 per pill, there’ll be an equivalent.”
‘Pharma bro’ Martin Shkreli gouged kids with kidney disease before ripping off AIDS patients
Clinton tweet on ‘outrageous’ price-gouging by pharmaceutical CEO causes biotech stocks to crash
CBS reporter grills pharmaceutical CEO: ‘You see how greedy this move looks’
Bolling’s colleague Greg Gutfeld also defended Shkreli’s actions from a business standpoint, while saying he found the Turing Pharmaceutical CEO “kind of skeevy.”
“Price control is not gonna stop this,” Gutfeld said. “What we have to do is get rid of the regulations that slow the development. It takes 10 years, $10 billion — thank you, John Stossel for that fact — to get approved by the FDA”
Watch the discussion, as posted by Media Matters, below.